Literature DB >> 20473400

Integration of multiple signaling pathway activities resolves K-RAS/N-RAS mutation paradox in colon epithelial cell response to inflammatory cytokine stimulation.

Pamela K Kreeger1, Yufang Wang, Kevin M Haigis, Douglas A Lauffenburger.   

Abstract

Colon tumors frequently harbor mutation in K-RAS and/or N-RAS, members of a GTPase family operating as a central hub for multiple key signaling pathways. While these proteins are strongly homologous, they exhibit diverse downstream effects on cell behavior. Utilizing an isogenic panel of human colon carcinoma cells bearing oncogenic mutations in K-RAS and/or N-RAS, we observed that K-RAS and double mutants similarly yield elevated apoptosis in response to treatment with TNFalpha compared to N-RAS mutants. Regardless, and in surprising contrast, key phospho-protein signals were more similar between N-RAS and dual mutants. This apparent contradiction could not be explained by any of the key signals individually, but a multi-pathway model constructed from the single-mutant cell line data was able to predict the behavior of the dual-mutant cell line. This success arises from a quantitative integration of multiple pro-apoptotic (pIkappaBalpha, pERK2) and pro-survival (pJNK, pHSP27) signals in manner not easily discerned from intuitive inspection.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 20473400      PMCID: PMC3687524          DOI: 10.1039/b925935j

Source DB:  PubMed          Journal:  Integr Biol (Camb)        ISSN: 1757-9694            Impact factor:   2.192


  18 in total

1.  A systems model of signaling identifies a molecular basis set for cytokine-induced apoptosis.

Authors:  Kevin A Janes; John G Albeck; Suzanne Gaudet; Peter K Sorger; Douglas A Lauffenburger; Michael B Yaffe
Journal:  Science       Date:  2005-12-09       Impact factor: 47.728

2.  An inducible autocrine cascade regulates rat hepatocyte proliferation and apoptosis responses to tumor necrosis factor-alpha.

Authors:  Benjamin D Cosgrove; Connie Cheng; Justin R Pritchard; Donna B Stolz; Douglas A Lauffenburger; Linda G Griffith
Journal:  Hepatology       Date:  2008-07       Impact factor: 17.425

3.  Detection of high incidence of K-ras oncogenes during human colon tumorigenesis.

Authors:  K Forrester; C Almoguera; K Han; W E Grizzle; M Perucho
Journal:  Nature       Date:  1987 May 28-Jun 3       Impact factor: 49.962

4.  The Role of Inflammation in the Pathogenesis of Colorectal Cancer.

Authors:  Beth B McConnell; Vincent W Yang
Journal:  Curr Colorectal Cancer Rep       Date:  2009-04-01

5.  The response of human epithelial cells to TNF involves an inducible autocrine cascade.

Authors:  Kevin A Janes; Suzanne Gaudet; John G Albeck; Ulrik B Nielsen; Douglas A Lauffenburger; Peter K Sorger
Journal:  Cell       Date:  2006-03-24       Impact factor: 41.582

6.  Oncogenic K-RAS subverts the antiapoptotic role of N-RAS and alters modulation of the N-RAS:gelsolin complex.

Authors:  J W Keller; K M Haigis; J L Franklin; R H Whitehead; T Jacks; R J Coffey
Journal:  Oncogene       Date:  2006-11-20       Impact factor: 9.867

7.  Cellular N-Ras promotes cell survival by downregulation of Jun N-terminal protein kinase and p38.

Authors:  Janice C Wolfman; Todd Palmby; Channing J Der; Alan Wolfman
Journal:  Mol Cell Biol       Date:  2002-03       Impact factor: 4.272

8.  Altered growth of human colon cancer cell lines disrupted at activated Ki-ras.

Authors:  S Shirasawa; M Furuse; N Yokoyama; T Sasazuki
Journal:  Science       Date:  1993-04-02       Impact factor: 47.728

9.  RAS mutations affect tumor necrosis factor-induced apoptosis in colon carcinoma cells via ERK-modulatory negative and positive feedback circuits along with non-ERK pathway effects.

Authors:  Pamela K Kreeger; Roli Mandhana; Shannon K Alford; Kevin M Haigis; Douglas A Lauffenburger
Journal:  Cancer Res       Date:  2009-09-29       Impact factor: 12.701

10.  Cancer: A tumour gene's fatal flaws.

Authors:  Julian Downward
Journal:  Nature       Date:  2009-11-05       Impact factor: 49.962

View more
  9 in total

1.  A multivariate model of ErbB network composition predicts ovarian cancer cell response to canertinib.

Authors:  Rexxi D Prasasya; Kang Z Vang; Pamela K Kreeger
Journal:  Biotechnol Bioeng       Date:  2011-08-23       Impact factor: 4.530

Review 2.  Cell signaling regulation by protein phosphorylation: a multivariate, heterogeneous, and context-dependent process.

Authors:  Evan K Day; Nisha G Sosale; Matthew J Lazzara
Journal:  Curr Opin Biotechnol       Date:  2016-07-06       Impact factor: 9.740

3.  Experimental and computational analysis of cellular interactions with nylon-3-bearing substrates.

Authors:  Runhui Liu; Kang Z Vang; Pamela K Kreeger; Samuel H Gellman; Kristyn S Masters
Journal:  J Biomed Mater Res A       Date:  2012-05-24       Impact factor: 4.396

4.  A simplified culture system to examine soluble factor interactions between mammalian cells.

Authors:  Molly J Carroll; Lauren E Stopfer; Pamela K Kreeger
Journal:  Chem Commun (Camb)       Date:  2013-11-14       Impact factor: 6.222

5.  Using partial least squares regression to analyze cellular response data.

Authors:  Pamela K Kreeger
Journal:  Sci Signal       Date:  2013-04-16       Impact factor: 8.192

Review 6.  Ras trafficking, localization and compartmentalized signalling.

Authors:  Ian A Prior; John F Hancock
Journal:  Semin Cell Dev Biol       Date:  2011-09-08       Impact factor: 7.727

7.  A comprehensive survey of Ras mutations in cancer.

Authors:  Ian A Prior; Paul D Lewis; Carla Mattos
Journal:  Cancer Res       Date:  2012-05-15       Impact factor: 12.701

Review 8.  Tuning cell migration: contractility as an integrator of intracellular signals from multiple cues.

Authors:  Francois Bordeleau; Cynthia A Reinhart-King
Journal:  F1000Res       Date:  2016-07-26

9.  Hierarchy of cellular decisions in collective behavior: Implications for wound healing.

Authors:  Lisa E Wickert; Shaun Pomerenke; Isaiah Mitchell; Kristyn S Masters; Pamela K Kreeger
Journal:  Sci Rep       Date:  2016-02-02       Impact factor: 4.379

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.